MOEBIUS; Ulrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOEBIUS; Ulrich.The latest application filed is for "il-2/il-15r beta gamma agonist dosing regimens for treating cancer or infectious diseases".

Company Profile

3.9.16

MOEBIUS; Ulrich - Gauting- Unterbrunn DE
Moebius; Ulrich - Gauting DE
Moebius, Ulrich - Unterbrunn DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Il-2/il-15r Beta Gamma Agonist Dosing Regimens For Treating Cancer Or Infectious Diseases App 20220241375 - MOEBIUS; Ulrich ; et al.	2022-08-04
Anti-cancer Fusion Polypeptide App 20210198380 - Hinner; Marlon ; et al.	2021-07-01
Anti-cancer fusion polypeptide Grant 10,865,250 - Hinner , et al. December 15, 2	2020-12-15
Medicament For The Treatment Of Viral Skin And Tumour Diseases App 20200054552 - CHANG; Yunik ; et al.	2020-02-20
Medicament for the treatment of viral skin and tumour diseases Grant 10,434,059 - Chang , et al. O	2019-10-08
Anti-cancer Fusion Polypeptide App 20190010248 - HINNER; Marlon ; et al.	2019-01-10
Medicament For The Treatment Of Viral Skin And Tumour Diseases App 20180193254 - CHANG; Yunik ; et al.	2018-07-12
Medicament for the treatment of viral skin and tumour diseases Grant 9,770,406 - Chang , et al. September 26, 2	2017-09-26
Treatment of tumors using specific anti-L1 antibody Grant 9,260,521 - Kelm , et al. February 16, 2	2016-02-16
Treatment Of Tumors Using Specific Anti-l1 Antibody App 20140120117 - Kelm; Daniela ; et al.	2014-05-01
Treatment of tumors using specific anti-L1 antibody Grant 8,580,258 - Kelm , et al. November 12, 2	2013-11-12
Medicament For The Treatment Of Viral Skin And Tumour Diseases App 20110009481 - Chang; Yunik ; et al.	2011-01-13
Medicament for the treatment of viral skin and tumour diseases Grant 7,858,662 - Chang , et al. December 28, 2	2010-12-28
Scleroprotein Of An Adeno-associated Virus With Modified Chromatographic Properties, The Production Thereof And Use Of The Same App 20100105123 - Hallek; Michael ; et al.	2010-04-29
Scleroprotein Of An Adeno-associated Virus With Modified Chromatographic Properties, The Production Thereof And Use Of The Same App 20090246854 - Hallek; Michael ; et al.	2009-10-01
Scleroprotein Of An Adeno Associated Virus With Modified Chromatographic Properties, The Production Thereof And Use Of The Same App 20090098634 - HALLEK; Michael ; et al.	2009-04-16
Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same App 20080241906 - Hallek; Michael ; et al.	2008-10-02
Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same Grant 7,285,381 - Hallek , et al. October 23, 2	2007-10-23
Medicament for the treatment of viral skin and tumour diseases App 20050032895 - Chang, Yunik ; et al.	2005-02-10
Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cell App 20050025789 - Nieland, John ; et al.	2005-02-03
Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof App 20040087026 - Bertran, Joan ; et al.	2004-05-06
Method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate and transfected cell App 20040053410 - Horer, Markus ; et al.	2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.